Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy
- PMID: 16885178
- DOI: 10.1259/bjr/17000205
Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy
Abstract
The aim of this study was to compare oesophageal abnormalities observed in high-resolution CT with radionuclide transit in patients with systemic sclerosis. 76 patients with systemic sclerosis were evaluated by high-resolution CT and oesophageal transit scintigraphy. Residual activity > or =20% (in relation to peak activity) at 15 s after the beginning of the swallow of the labelled liquid (in supine position) was considered indicative of oesophageal dysfunction. Supra-aortic and infra-aortic oesophageal coronal diameters were measured in high-resolution CT. Oesophageal dilatation was deemed present when the diameters exceeded 10 mm. 19 patients (25%) had supra-aortic oesophageal dilatation and 48 patients (63.1%) had infra-aortic dilatation. The prevalence of radionuclide transit delay was 77.6%. All patients (19/19) with supra-aortic dilatation had oesophageal dysfunction, compared with 70.2% (40/57) of the patients with no supra-aortic dilatation (p = 0.004). Oesophageal dysfunction was present in 97.9% (47/48) of patients with infra-aortic dilatation, compared with 42.9% (12/28) in patients without it (p < 0.001). Receiver operating characteristic (ROC) curves have demonstrated that the supra-aortic and infra-aortic diameters had good discriminatory capacity for oesophageal dysfunction in systemic sclerosis (area under the curve, 95% confidence interval: 0.80, 0.70-0.89 and 0.92, 0.86-0.98, respectively). There is a clinically significant association between oesophageal dysmotility and high-resolution CT findings of oesophageal coronal dilatation. The evaluation of infra-aortic oesophageal coronal diameter can provide additional useful information about the functional and anatomic conditions of the oesophagus in systemic sclerosis.
Similar articles
-
Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: what does it signify?J Med Imaging Radiat Oncol. 2011 Dec;55(6):551-5. doi: 10.1111/j.1754-9485.2011.02317.x. J Med Imaging Radiat Oncol. 2011. PMID: 22141601
-
Solid-phase radionuclide esophageal transit in progressive systemic sclerosis.Hepatogastroenterology. 2002 Jul-Aug;49(46):989-91. Hepatogastroenterology. 2002. PMID: 12143260
-
Oesophageal motility disorders: rapid functional diagnosis using computerised radionuclide oesophageal transit study.Singapore Med J. 1995 Jun;36(3):309-13. Singapore Med J. 1995. PMID: 8553100 Clinical Trial.
-
Dysmotility and reflux disease.Curr Opin Otolaryngol Head Neck Surg. 2013 Dec;21(6):548-56. doi: 10.1097/MOO.0b013e3283658edf. Curr Opin Otolaryngol Head Neck Surg. 2013. PMID: 24240131 Review.
-
Esophageal transit scintigraphy in children: a user's guide and pictorial review.Pediatr Radiol. 2019 May;49(5):663-677. doi: 10.1007/s00247-018-4301-y. Epub 2018 Dec 7. Pediatr Radiol. 2019. PMID: 30535870 Review.
Cited by
-
Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.Semin Arthritis Rheum. 2016 Aug;46(1):109-14. doi: 10.1016/j.semarthrit.2016.02.004. Epub 2016 Feb 26. Semin Arthritis Rheum. 2016. PMID: 27033049 Free PMC article.
-
GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.Curr Rheumatol Rep. 2019 Jul 3;21(8):42. doi: 10.1007/s11926-019-0841-x. Curr Rheumatol Rep. 2019. PMID: 31270707 Free PMC article. Review.
-
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation.Rheumatology (Oxford). 2023 Feb 6;62(SI):SI32-SI42. doi: 10.1093/rheumatology/keac319. Rheumatology (Oxford). 2023. PMID: 35686921 Free PMC article.
-
Development of a Diagnostic Model Focusing on Esophageal Dysmotility in Patients with Systemic Sclerosis.Diagnostics (Basel). 2022 Dec 13;12(12):3142. doi: 10.3390/diagnostics12123142. Diagnostics (Basel). 2022. PMID: 36553149 Free PMC article.
-
The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.Arthritis Res Ther. 2016 Sep 1;18(1):195. doi: 10.1186/s13075-016-1094-y. Arthritis Res Ther. 2016. PMID: 27586891 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical